Interferon alfa-2a biosimilar (Laboratorios Bioprofarma)

干扰素α-2a生物类似药 (Laboratorios Bioprofarma)

Report date: 2022/02/17 14:59:56

Base Information

Drug NameInterferon alfa-2a biosimilar (Laboratorios Bioprofarma)
Drug Alias Name干扰素α-2a生物仿制药 (Laboratorios Bioprofarma)Infostat
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsLeukemia, Hairy CellHepatitis CSarcoma, Kaposi
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Bioprofarma
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Bioprofarma
Inactive CompaniesN/A
Active IndicationsLeukemia, Hairy CellHepatitis CSarcoma, Kaposi
Inactive IndicationsN/A

Other Information

ATC CodeL03AB04
Related LinksN/A